EyEM, Freepik.comDenmarkThe rollercoaster ride stopps and danish IO Biotech goes bustThe Copenhagen-based cancer immunotherapy company IO Biotech has come to an abrupt end, marking one of the more sobering recent failures in Europe’s mid-cap biotech segment. Founded in 2019, the company … more ➔
GenerareArtificial intelligenceFrench AI: 20 million funding for Generare to find better data in natureFrench Generare, founded in 2023, is positioning itself at the intersection of synthetic biology and artificial intelligence by tackling what many in the sector now see as a fundamental bottleneck: the … more ➔
M&ALilly moves deeper into sleep medicine with up to $7.8 billion Centessa dealEli Lilly has agreed to acquire UK-based Centessa Pharmaceuticals in a deal worth up to $7.8 billion, giving the pharma giant a high-profile entry into one of biotech’s most closely watched neuroscience … more ➔
Novartis GroupSwitzerlandSomething of a shopping spree: Novartis to acquire US-based Excellergy for up to $2bnNovartis is back on the acquisition trail, agreeing to buy California-based Excellergy for up to $2bn. The antibody Exl-111 is intended to strengthen its allergy pipeline and go beyond the current standard … more ➔
Ethris GmbHVaccinationEurope’s pivotal choice: Vaccination is health securityThe COVID 19 pandemic demonstrated that Europe can move fast, take risk, and deliver world class vaccines when political will, science and capital are aligned. Treating vaccines as strategic assets, … more ➔
Kelli McClintock auf UnsplashStartups10 European Startups to watch in 2026Ten young European biotechs are heading into 2026 with the kind of momentum that can quickly turn promising science into defining data: first clinical entries, platform-to-pipeline transitions, and funding … more ➔
Ysios CapitalFundingYsios Capital launches InceptionBio: €100m for Spanish biotech spinoutsSpanish VC firm Ysios Capital has unveiled InceptionBio, a €100 million fund dedicated to boosting Spanish biotech innovation. The initiative targets company creation from top-tier research, backed … more ➔
123rf.com/Paul GrecaudFinancingEIF starts €15bn fund-of-funds for scaling European tech companiesThe European Investment Fund has launched a new fund of funds with a target volume of €15 billion to strengthen growth financing in Europe’s technology sector. The programme is considered the largest … more ➔
Unsplash+FundraisingTenBoron lands €7.6m EU grant for precision radiotherapy trials in hard-to-treat cancersFinnish clinical stage biotech TenBoron Oy has landed a €7.6m grant from the European Union’s Horizon Europe Health 2025 programme. The funding will propel its boron carrier platform for a novel … more ➔
Unsplash+FinancingImmutrin secures £65m Series A for amyloid-removing heart therapyImmutrin, a UK biotech, has raised £65m (€75m) in Series A funding for a pioneering antibody designed to remove pre-existing amyloid deposits in amyloidosis. more ➔
EyEM, Freepik.com
Generare
Novartis Group
Ethris GmbH
Kelli McClintock auf Unsplash
Ysios Capital
123rf.com/Paul Grecaud
Unsplash+
Unsplash+